Asthma in the intensive care unit: A review of patient characteristics and outcomes
Main Article Content
Abstract
Background. Most asthma-related deaths occur in low- and middle-income countries, and South Africa (SA) is ranked fifth in global asthma mortality. Little is known about the characteristics and outcome of asthma patients requiring intensive care unit (ICU) admission in SA.
Objectives. To identify and characterise patients with acute severe asthma admitted to the respiratory ICU at Groote Schuur Hospital, Cape Town, SA, in order to evaluate outcomes and identify predictors of poor outcomes in those admitted.
Methods. We performed a retrospective descriptive study of patients with severe asthma admitted to the respiratory ICU at Groote Schuur Hospital between 1 January 2014 and 31 December 2019.
Results. One hundred and three patients (110 admission episodes) were identified with an acute asthma exacerbation requiring ICU admission; all were mechanically ventilated. There was a female preponderance (53.6%; n=59/110), with a median (range) age overall of 33 (13 - 84) years. Of all admissions, 40 (36.4%) were current tobacco smokers and 16 (14.5%) patients with a history of substance abuse. Two thirds (60.0%; n=66/110) of the patients were using an inhaled corticosteroid (ICS). No predictors of mortality were evident in multivariate modelling, although those who died were older, and had higher Acute Physiology and Chronic Health Evaluation (APACHE II) scores and longer duration of admission. Only 59 of the surviving 96 individual patients (61.5%) attended a specialist pulmonology clinic after discharge.
Conclusion. Among patients admitted to the respiratory ICU at Groote Schuur Hospital for asthma exacerbations, there was a high prevalence of smokers and poor coverage with inhaled ICSs. Although mortality was low compared with general ICU mortality, more needs to be done to prevent acute severe asthma exacerbations.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
How to Cite
References
Brakema EA, Tabyshova A, van der Kleij R, et al. The socioeconomic burden of chronic lung disease in low-resource settings across the globe – an observational FRESH AIR study. Respir Res 2019;20:291. https://doi.org/10.1186/s12931-019-1255-z
Sinharoy A, Mitra S, Mondal P. Socioeconomic and environmental predictors of asthma-related mortality. J Environ Public Health 2018;2018:9389570. https://doi.org/10.1155/2018/9389570
Grant EN, Lyttle CS, Weiss KB. The relation of socioeconomic factors and racial/ethnic differences in US asthma mortality. Am J Public Health 2000;90(12):1923-1925. https://doi.org/10.2105/ajph.90.12.1923
Gibbison B, Griggs K, Mukherjee M, Sheikh A. Ten years of asthma admissions to adult critical care units in England and Wales. BMJ Open 2013;3(9):e003420. https://doi.org/10.1136/bmjopen-2013-003420
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2021. https://ginasthma.org/wp-content/uploads/2023/04/GINA-Main-Report-2021-V2-WMSA.pdf (accessed August 2021).
Zar HJ, Stickells D, Toerien A, Wilson D, Klein M, Bateman ED. Changes in fatal and near-fatal asthma in an urban area of South Africa from 1980 - 1997. Eur Respir J 2001;18(1):33-37. https://doi.org/10.1183/09031936.01.00081801
Demoule A, Brochard L, Dres M, et al. How to ventilate obstructive and asthmatic patients. Intensive Care Med 2020;46(12):2436-2449. https://doi.org/10.1007/s00134-020-06291-0
Westerman DE, Benatar SR, Potgieter PD, Ferguson AD. Identification of the high risk asthmatic patient: Experience with 39 patients undergoing ventilation for status asthmaticus. Am J Med 1979;66(4):565-572. https://doi.org/10.1016/0002-
(79)91165-3
Gonem S, Cumella A, Richardson M. Asthma admission rates and patterns of salbutamol and inhaled corticosteroid prescribing in England from 2013 to 2017. Thorax 2019;74(7):705-706. https://doi.org/10.1136/thoraxjnl-2018-212723
Weatherall M, Wijesinghe M, Perrin K, Harwood M, Beasley R. Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy. Thorax 2010;65(1):39-43. https://doi.org/10.1136/thx.2009.116608
O’Byrne P, Fabbri LM, Pavord ID, Papi A, Petruzzelli S, Lange P. Asthma progression and mortality: The role of inhaled corticosteroids. Eur Respir J 2019;54(1):1900491. https://doi.org/10.1183/13993003.00491-2019
Juárez León JE, Gonzalez Islas D, Sandoval Gutierrez JL, Miguel Reyes JL, Orea Tejeda A. Risk factors for hospitalisation and ICU admission for near-fatal asthma. Eur Respir J 2017;50(suppl 61):PA3575. https://doi.org/10.1183/1393003.congress-2017.PA3575
Eisner MD, Lieu TA, Chi F, et al. Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J 2001;17(2):233-240. https://doi.org/10.1183/09031936.01.17202330
Nakwan N, Prateepchaiboon T. Predicting the requiring intubation and invasive mechanical ventilation among asthmatic exacerbation-related hospitalisations. J Asthma 2022;59(3):507-513. https://doi.org/10.1080/02770903.2020.1853768
Reddy P, Zuma K, Shisana O, Kim J, Sewpaul R. Prevalence of tobacco use among adults in South Africa: Results from the first South African National Health and Nutrition Examination Survey. S Afr Med J 2015;105(8):648-655. https://doi.
org/10.7196/SAMJnew.7932
Levine M, Iliescu ME, Margellos-Anast H, Estarziau M, Ansell DA. The effects of cocaine and heroin use on intubation rates and hospital utilisation in patients with acute asthma exacerbations. Chest 2005;128(4):1951-1957. https://doi.org/10.1378/
chest.128.4.1951
Polosa R, Thomson NC. Smoking and asthma: Dangerous liaisons. Eur Respir J 2013;41(3):716-726. https://doi.org/10.1183/09031936.00073312
Caponnetto P, Auditore R, Russo C, et al. ‘Dangerous relationships’: Asthma and substance abuse. J Addict Dis 2013;32(2):158-167. https://doi.org/10.1080/10550887.2013.795469